Literature DB >> 21272615

Proteomic changes in the brains of Huntington's disease mouse models reflect pathology and implicate mitochondrial changes.

Mia Deschepper1, Bastiaan Hoogendoorn, Simon Brooks, Stephen B Dunnett, Lesley Jones.   

Abstract

Mouse models of Huntington's disease (HD) have been used extensively to recapitulate the pathological cascade of events in human HD. Mutant huntingtin interacts with many other proteins and has a well documented effect on gene expression. We were interested in whether changes in gene expression were translated into changes in the protein abundance in the brains of mouse models of HD. In two different HD knock in mouse models, the HdhQ150 and the HdhQ92, we detected changes in the abundance of proteins in mouse brain between wild-type and homozygous mutant animals. The numbers of changes detected rose with age and phenotypic severity. There were regional differences with most changes seen in the caudate and fewest in the cerebellum, reflecting the known pattern of gene expression changes in human HD and mouse models of HD and the known pathology. However, while some changes in the proteome followed changes in gene expression others did not directly reflect changes in gene expression seen in these animal models. Seven of the sixteen proteins detected have a known mitochondrial function, an enrichment of six-fold over that expected (p=0.001): these mitochondrial proteins show both increases and decreases in abundance implying that a straightforward alteration in mitochondrial number is unlikely to account for this finding.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21272615     DOI: 10.1016/j.brainresbull.2011.01.012

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  10 in total

Review 1.  Energy dysfunction in Huntington's disease: insights from PGC-1α, AMPK, and CKB.

Authors:  Tz-Chuen Ju; Yow-Sien Lin; Yijuang Chern
Journal:  Cell Mol Life Sci       Date:  2012-05-25       Impact factor: 9.261

2.  Carnosic Acid Suppresses the H2O2-Induced Mitochondria-Related Bioenergetics Disturbances and Redox Impairment in SH-SY5Y Cells: Role for Nrf2.

Authors:  Marcos Roberto de Oliveira; Gustavo da Costa Ferreira; Alessandra Peres; Simone Morelo Dal Bosco
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

3.  Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23.

Authors:  Svitlana Yablonska; Vinitha Ganesan; Lisa M Ferrando; JinHo Kim; Anna Pyzel; Oxana V Baranova; Nicolas K Khattar; Timothy M Larkin; Sergei V Baranov; Ning Chen; Colleen E Strohlein; Donté A Stevens; Xiaomin Wang; Yue-Fang Chang; Mark E Schurdak; Diane L Carlisle; Jonathan S Minden; Robert M Friedlander
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-25       Impact factor: 11.205

4.  Novel proteomic changes in brain mitochondria provide insights into mitochondrial dysfunction in mouse models of Huntington's disease.

Authors:  Sonal Agrawal; Jonathan H Fox
Journal:  Mitochondrion       Date:  2019-03-20       Impact factor: 4.160

Review 5.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

6.  Tracking brain palmitoylation change: predominance of glial change in a mouse model of Huntington's disease.

Authors:  Junmei Wan; Jeffrey N Savas; Amy F Roth; Shaun S Sanders; Roshni R Singaraja; Michael R Hayden; John R Yates; Nicholas G Davis
Journal:  Chem Biol       Date:  2013-11-07

7.  Anatomo-proteomic characterization of human basal ganglia: focus on striatum and globus pallidus.

Authors:  Joaquín Fernández-Irigoyen; María Victoria Zelaya; Teresa Tuñon; Enrique Santamaría
Journal:  Mol Brain       Date:  2014-11-18       Impact factor: 4.041

Review 8.  Juvenile Huntington's Disease and Other PolyQ Diseases, Update on Neurodevelopmental Character and Comparative Bioinformatic Review of Transcriptomic and Proteomic Data.

Authors:  Karolina Świtońska-Kurkowska; Bart Krist; Joanna Delimata; Maciej Figiel
Journal:  Front Cell Dev Biol       Date:  2021-07-01

Review 9.  Taming the Huntington's Disease Proteome: What Have We Learned?

Authors:  Connor Seeley; Kimberly B Kegel-Gleason
Journal:  J Huntingtons Dis       Date:  2021

Review 10.  Mouse models of polyglutamine diseases: review and data table. Part I.

Authors:  Maciej Figiel; Wojciech J Szlachcic; Pawel M Switonski; Agnieszka Gabka; Wlodzimierz J Krzyzosiak
Journal:  Mol Neurobiol       Date:  2012-09-07       Impact factor: 5.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.